

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.35729928 |
| 2 | nuclear pore complex assembly (GO:0051292) | 5.87184616 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.84470638 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.79354938 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.43699334 |
| 6 | glutamate secretion (GO:0014047) | 5.15107480 |
| 7 | nuclear pore organization (GO:0006999) | 5.00791068 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.97424558 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.80832767 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.78543667 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.51626149 |
| 12 | proline transport (GO:0015824) | 4.48887088 |
| 13 | layer formation in cerebral cortex (GO:0021819) | 4.48819063 |
| 14 | sodium ion export (GO:0071436) | 4.43898371 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 4.35622714 |
| 16 | COPI coating of Golgi vesicle (GO:0048205) | 4.35622714 |
| 17 | vocalization behavior (GO:0071625) | 4.35388293 |
| 18 | exploration behavior (GO:0035640) | 4.23898659 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.22893505 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.22689621 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.20640921 |
| 22 | pore complex assembly (GO:0046931) | 4.17237825 |
| 23 | hypotonic response (GO:0006971) | 4.14374928 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.03108125 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.02722117 |
| 26 | protein localization to endosome (GO:0036010) | 4.00444281 |
| 27 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.94781408 |
| 28 | activation of protein kinase A activity (GO:0034199) | 3.94566405 |
| 29 | iron ion import (GO:0097286) | 3.90391264 |
| 30 | regulation of ARF protein signal transduction (GO:0032012) | 3.79448549 |
| 31 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76339030 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.74424422 |
| 33 | embryonic process involved in female pregnancy (GO:0060136) | 3.72592648 |
| 34 | mitotic sister chromatid cohesion (GO:0007064) | 3.72432765 |
| 35 | protein localization to synapse (GO:0035418) | 3.68844838 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.64794558 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.64145536 |
| 38 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.59050582 |
| 39 | COPII vesicle coating (GO:0048208) | 3.58070891 |
| 40 | regulation of histone H3-K27 methylation (GO:0061085) | 3.57178725 |
| 41 | vesicle transport along microtubule (GO:0047496) | 3.56929765 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.48566158 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.43646202 |
| 44 | neurotransmitter transport (GO:0006836) | 3.40399075 |
| 45 | neuromuscular process controlling balance (GO:0050885) | 3.36578292 |
| 46 | glycine transport (GO:0015816) | 3.34086627 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 3.33621142 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.31640200 |
| 49 | necroptotic process (GO:0070266) | 3.31471726 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.31410999 |
| 51 | neuronal action potential propagation (GO:0019227) | 3.30966967 |
| 52 | dendritic spine morphogenesis (GO:0060997) | 3.30533779 |
| 53 | vesicle coating (GO:0006901) | 3.25746741 |
| 54 | dendrite morphogenesis (GO:0048813) | 3.23124865 |
| 55 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.22203408 |
| 56 | neuromuscular process controlling posture (GO:0050884) | 3.20985126 |
| 57 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.18129459 |
| 58 | long-term memory (GO:0007616) | 3.16980232 |
| 59 | proline biosynthetic process (GO:0006561) | 3.16739870 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.15124282 |
| 61 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11425364 |
| 62 | clathrin coat assembly (GO:0048268) | 3.10601259 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.08971199 |
| 64 | hepatocyte apoptotic process (GO:0097284) | 3.08965145 |
| 65 | cell communication by electrical coupling (GO:0010644) | 3.08862820 |
| 66 | organelle transport along microtubule (GO:0072384) | 3.07930064 |
| 67 | alanine transport (GO:0032328) | 3.06086751 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.02254975 |
| 69 | prepulse inhibition (GO:0060134) | 3.01622136 |
| 70 | synaptic vesicle endocytosis (GO:0048488) | 3.01269762 |
| 71 | cell adhesion mediated by integrin (GO:0033627) | 2.99489469 |
| 72 | membrane raft organization (GO:0031579) | 2.99451386 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 2.99131745 |
| 74 | potassium ion import (GO:0010107) | 2.98466712 |
| 75 | axon cargo transport (GO:0008088) | 2.98064092 |
| 76 | positive regulation of membrane potential (GO:0045838) | 2.97994531 |
| 77 | regulation of synaptic plasticity (GO:0048167) | 2.97850877 |
| 78 | establishment of nucleus localization (GO:0040023) | 2.97690243 |
| 79 | neuron-neuron synaptic transmission (GO:0007270) | 2.97225857 |
| 80 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.96804178 |
| 81 | regulation of neurotransmitter secretion (GO:0046928) | 2.96705717 |
| 82 | regulation of RNA export from nucleus (GO:0046831) | 2.95125747 |
| 83 | regulation of postsynaptic membrane potential (GO:0060078) | 2.94279754 |
| 84 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.93957868 |
| 85 | glutamate receptor signaling pathway (GO:0007215) | 2.92687159 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92419424 |
| 87 | cellular sodium ion homeostasis (GO:0006883) | 2.89131366 |
| 88 | social behavior (GO:0035176) | 2.87816964 |
| 89 | intraspecies interaction between organisms (GO:0051703) | 2.87816964 |
| 90 | regulation of response to tumor cell (GO:0002834) | 2.87793265 |
| 91 | positive regulation of response to tumor cell (GO:0002836) | 2.87793265 |
| 92 | positive regulation of immune response to tumor cell (GO:0002839) | 2.87793265 |
| 93 | regulation of immune response to tumor cell (GO:0002837) | 2.87793265 |
| 94 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.86939516 |
| 95 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.86243889 |
| 96 | mating behavior (GO:0007617) | 2.84543104 |
| 97 | innervation (GO:0060384) | 2.83945297 |
| 98 | nerve growth factor signaling pathway (GO:0038180) | 2.83413434 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81326116 |
| 100 | mammary gland epithelial cell proliferation (GO:0033598) | 2.80611506 |
| 101 | long-term synaptic potentiation (GO:0060291) | 2.79781513 |
| 102 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.79622980 |
| 103 | cellular response to ethanol (GO:0071361) | 2.79318215 |
| 104 | regulation of vesicle fusion (GO:0031338) | 2.75594823 |
| 105 | protein localization to microtubule (GO:0035372) | 2.74666033 |
| 106 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.74568240 |
| 107 | response to auditory stimulus (GO:0010996) | 2.73590482 |
| 108 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.73552785 |
| 109 | regulation of neurotransmitter transport (GO:0051588) | 2.73086327 |
| 110 | programmed necrotic cell death (GO:0097300) | 2.71569283 |
| 111 | response to histamine (GO:0034776) | 2.69794208 |
| 112 | necrotic cell death (GO:0070265) | 2.68822503 |
| 113 | neuromuscular process (GO:0050905) | 2.68368611 |
| 114 | membrane depolarization during action potential (GO:0086010) | 2.67926043 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.67656139 |
| 116 | protein export from nucleus (GO:0006611) | 2.67643273 |
| 117 | negative regulation of DNA repair (GO:0045738) | 2.67136656 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.66109986 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.64480584 |
| 120 | neuron recognition (GO:0008038) | 2.63873004 |
| 121 | negative regulation of fatty acid transport (GO:2000192) | 2.63757293 |
| 122 | skin morphogenesis (GO:0043589) | 2.63309219 |
| 123 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.63005371 |
| 124 | dopamine receptor signaling pathway (GO:0007212) | 2.62968900 |
| 125 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.62956954 |
| 126 | peptidyl-threonine modification (GO:0018210) | 2.62599222 |
| 127 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61507164 |
| 128 | mitotic chromosome condensation (GO:0007076) | 2.60701492 |
| 129 | potassium ion homeostasis (GO:0055075) | 2.60663856 |
| 130 | suckling behavior (GO:0001967) | 2.60257486 |
| 131 | membrane hyperpolarization (GO:0060081) | 2.59173204 |
| 132 | cell migration in hindbrain (GO:0021535) | 2.58685927 |
| 133 | positive regulation of synaptic transmission (GO:0050806) | 2.58005122 |
| 134 | chemosensory behavior (GO:0007635) | 2.57392284 |
| 135 | auditory behavior (GO:0031223) | 2.57021964 |
| 136 | membrane repolarization (GO:0086009) | 2.55144772 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.54749862 |
| 138 | activation of Rac GTPase activity (GO:0032863) | 2.54085280 |
| 139 | protein targeting to Golgi (GO:0000042) | 2.53606046 |
| 140 | L-amino acid import (GO:0043092) | 2.52963804 |
| 141 | definitive hemopoiesis (GO:0060216) | 2.52889601 |
| 142 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52835395 |
| 143 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52215706 |
| 144 | membrane depolarization (GO:0051899) | 2.51197790 |
| 145 | axonal fasciculation (GO:0007413) | 2.51172662 |
| 146 | hemidesmosome assembly (GO:0031581) | 2.50346837 |
| 147 | peptidyl-threonine phosphorylation (GO:0018107) | 2.48539461 |
| 148 | megakaryocyte development (GO:0035855) | 2.47524838 |
| 149 | cell-substrate junction assembly (GO:0007044) | 2.47453075 |
| 150 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.46647128 |
| 151 | response to laminar fluid shear stress (GO:0034616) | 2.44497677 |
| 152 | regulation of necroptotic process (GO:0060544) | 2.43713514 |
| 153 | negative regulation of anoikis (GO:2000811) | 2.42656090 |
| 154 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.40027110 |
| 155 | dosage compensation (GO:0007549) | 2.36270399 |
| 156 | negative regulation of necroptotic process (GO:0060546) | 2.33586499 |
| 157 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.32896676 |
| 158 | regulation of protein localization to plasma membrane (GO:1903076) | 2.31053717 |
| 159 | regulation of mitotic spindle organization (GO:0060236) | 2.28339408 |
| 160 | regulation of early endosome to late endosome transport (GO:2000641) | 2.27474598 |
| 161 | regulation of spindle organization (GO:0090224) | 2.27217215 |
| 162 | regulation of anoikis (GO:2000209) | 2.26798875 |
| 163 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26373148 |
| 164 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.25248341 |
| 165 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.24288932 |
| 166 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.23590477 |
| 167 | focal adhesion assembly (GO:0048041) | 2.23104521 |
| 168 | cell-substrate adherens junction assembly (GO:0007045) | 2.23104521 |
| 169 | Golgi organization (GO:0007030) | 2.22472564 |
| 170 | B cell receptor signaling pathway (GO:0050853) | 2.21927564 |
| 171 | early endosome to late endosome transport (GO:0045022) | 2.21634417 |
| 172 | desmosome organization (GO:0002934) | 2.20688727 |
| 173 | membrane protein ectodomain proteolysis (GO:0006509) | 2.20240597 |
| 174 | cortical actin cytoskeleton organization (GO:0030866) | 2.18778028 |
| 175 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.18477909 |
| 176 | negative regulation of interleukin-17 production (GO:0032700) | 2.17578437 |
| 177 | hepatocyte differentiation (GO:0070365) | 2.16533626 |
| 178 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.15948769 |
| 179 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.15646355 |
| 180 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.15536881 |
| 181 | histone phosphorylation (GO:0016572) | 2.15484013 |
| 182 | cellular protein complex localization (GO:0034629) | 2.15379993 |
| 183 | pinocytosis (GO:0006907) | 2.12275290 |
| 184 | response to thyroid hormone (GO:0097066) | 2.12024874 |
| 185 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.11886343 |
| 186 | regulation of response to interferon-gamma (GO:0060330) | 2.11564331 |
| 187 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.10997534 |
| 188 | histone H3-K36 demethylation (GO:0070544) | 2.10435988 |
| 189 | viral entry into host cell (GO:0046718) | 2.10219236 |
| 190 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.09701894 |
| 191 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.08487956 |
| 192 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.08314823 |
| 193 | positive regulation of macrophage differentiation (GO:0045651) | 2.06739656 |
| 194 | positive regulation of receptor recycling (GO:0001921) | 2.06167707 |
| 195 | stress fiber assembly (GO:0043149) | 2.05585240 |
| 196 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.05318559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.02746880 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.95658549 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.95575952 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.77233150 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.54761290 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70698045 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.53261623 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.50788632 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48891026 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44371953 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.43987238 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.42079932 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.40525631 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39203815 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39107846 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37113534 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30746882 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26359967 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.24703176 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18066677 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16253868 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.13871872 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13709166 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13709166 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.09446174 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07750273 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06703184 |
| 28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.04277406 |
| 29 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.04277406 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02907958 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99249447 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.98638485 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.95095830 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89339449 |
| 35 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.89124395 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86764385 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85712689 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85711893 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.83147016 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82578221 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80129679 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79404809 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.76790876 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76162377 |
| 45 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.71200109 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70577433 |
| 47 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.70345406 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69861877 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69413020 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68336381 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66881907 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.66861109 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66435581 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65394369 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64205781 |
| 56 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.63276136 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60672291 |
| 58 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.60345428 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60016587 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58702293 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56960169 |
| 62 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55134522 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53744458 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51969090 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51880921 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50862749 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50200656 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49445897 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49107954 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49081911 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48634039 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.48117012 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46648853 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43243746 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42509026 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41624586 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41543695 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40965386 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.39700252 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39326563 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39038887 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.38707817 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37667983 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 1.37101607 |
| 85 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35904415 |
| 86 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35132809 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.34672234 |
| 88 | AR_19668381_ChIP-Seq_PC3_Human | 1.31931388 |
| 89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.30955645 |
| 90 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.30693739 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29841064 |
| 92 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.29365056 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28926985 |
| 94 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28759645 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27440132 |
| 96 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25973704 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25810895 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.25728790 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25592266 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25174705 |
| 101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24849675 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23839534 |
| 103 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.21862915 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20980362 |
| 105 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.20731134 |
| 106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20526148 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20365831 |
| 108 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17732721 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17476203 |
| 110 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.17330314 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17016564 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16865950 |
| 113 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16802071 |
| 114 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16485493 |
| 115 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16260281 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16187395 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15374399 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15320933 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15047485 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14969006 |
| 121 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13614693 |
| 122 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13418727 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13096691 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12584843 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.12289775 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 1.12117849 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11805712 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11193514 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10879919 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10785650 |
| 131 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10416166 |
| 132 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08204703 |
| 133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08117098 |
| 134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07954952 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07484244 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06910196 |
| 137 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05121030 |
| 138 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05037142 |
| 139 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04923927 |
| 140 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04794494 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04607054 |
| 142 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04529223 |
| 143 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03955831 |
| 144 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03873051 |
| 145 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02391188 |
| 146 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01664900 |
| 147 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01204610 |
| 148 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00955077 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00256499 |
| 150 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00091270 |
| 151 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99889559 |
| 152 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99617708 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99493244 |
| 154 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99171827 |
| 155 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98495777 |
| 156 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.98482075 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97824906 |
| 158 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97792797 |
| 159 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97523678 |
| 160 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97188326 |
| 161 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96750903 |
| 162 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96263280 |
| 163 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95905680 |
| 164 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95820148 |
| 165 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.95731266 |
| 166 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94912612 |
| 167 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94823762 |
| 168 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94141877 |
| 169 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94099843 |
| 170 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93286915 |
| 171 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92975892 |
| 172 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92660399 |
| 173 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91658557 |
| 174 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91654263 |
| 175 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91604570 |
| 176 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91484700 |
| 177 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90894162 |
| 178 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90804850 |
| 179 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90630633 |
| 180 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89969997 |
| 181 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.89781408 |
| 182 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89139786 |
| 183 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88298972 |
| 184 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88024754 |
| 185 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87855459 |
| 186 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.87825344 |
| 187 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87786011 |
| 188 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87627261 |
| 189 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86989610 |
| 190 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86979241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.72909331 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.01136493 |
| 3 | MP0004270_analgesia | 3.86416993 |
| 4 | MP0003880_abnormal_central_pattern | 3.72004874 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 3.58461173 |
| 6 | MP0008057_abnormal_DNA_replication | 3.19110454 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.12299051 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.10441501 |
| 9 | MP0009046_muscle_twitch | 3.01694856 |
| 10 | MP0009745_abnormal_behavioral_response | 2.97244423 |
| 11 | MP0002064_seizures | 2.95475428 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.92883024 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.69486484 |
| 14 | MP0002009_preneoplasia | 2.65702233 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.57354294 |
| 16 | MP0005451_abnormal_body_composition | 2.50705412 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.45163544 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.42475224 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.37081989 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.34305810 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.29793576 |
| 22 | MP0001486_abnormal_startle_reflex | 2.28968440 |
| 23 | MP0003329_amyloid_beta_deposits | 2.26664410 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.25686057 |
| 25 | MP0002822_catalepsy | 2.23366386 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.22375383 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 2.21922239 |
| 28 | MP0003566_abnormal_cell_adhesion | 2.21683687 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.19319541 |
| 30 | MP0004858_abnormal_nervous_system | 2.17302934 |
| 31 | MP0002272_abnormal_nervous_system | 2.14739928 |
| 32 | MP0002736_abnormal_nociception_after | 2.08793789 |
| 33 | MP0003763_abnormal_thymus_physiology | 2.08720429 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.98057403 |
| 35 | MP0001970_abnormal_pain_threshold | 1.93419210 |
| 36 | * MP0003091_abnormal_cell_migration | 1.91454755 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.87885068 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.86489927 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.85182514 |
| 40 | MP0008569_lethality_at_weaning | 1.84350939 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.79620413 |
| 42 | MP0004924_abnormal_behavior | 1.78511524 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.78511524 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.77517263 |
| 45 | MP0004885_abnormal_endolymph | 1.72690593 |
| 46 | MP0002006_tumorigenesis | 1.69816984 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.69143110 |
| 48 | MP0005409_darkened_coat_color | 1.68437987 |
| 49 | MP0003633_abnormal_nervous_system | 1.57794551 |
| 50 | MP0002184_abnormal_innervation | 1.54659584 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.53526816 |
| 52 | MP0000604_amyloidosis | 1.53413354 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.52662822 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.50167625 |
| 55 | MP0004947_skin_inflammation | 1.46963081 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.46462839 |
| 57 | MP0000778_abnormal_nervous_system | 1.42607416 |
| 58 | MP0000955_abnormal_spinal_cord | 1.41954376 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.40201691 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.39273378 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.38980942 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.36071944 |
| 63 | MP0003690_abnormal_glial_cell | 1.34596612 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.31493807 |
| 65 | MP0000858_altered_metastatic_potential | 1.31423718 |
| 66 | MP0003828_pulmonary_edema | 1.28866019 |
| 67 | MP0003631_nervous_system_phenotype | 1.28021394 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27443404 |
| 69 | MP0003303_peritoneal_inflammation | 1.25679978 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.25096328 |
| 71 | MP0003879_abnormal_hair_cell | 1.24911628 |
| 72 | MP0008260_abnormal_autophagy | 1.24393790 |
| 73 | MP0010307_abnormal_tumor_latency | 1.24300869 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.23075337 |
| 75 | MP0001851_eye_inflammation | 1.22779066 |
| 76 | MP0002229_neurodegeneration | 1.22318606 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.20678873 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.20575154 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.20356402 |
| 80 | MP0002060_abnormal_skin_morphology | 1.19980957 |
| 81 | MP0004130_abnormal_muscle_cell | 1.19182357 |
| 82 | MP0003787_abnormal_imprinting | 1.17813285 |
| 83 | * MP0005621_abnormal_cell_physiology | 1.17212437 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.16724200 |
| 85 | MP0005408_hypopigmentation | 1.16662814 |
| 86 | MP0010678_abnormal_skin_adnexa | 1.16524414 |
| 87 | MP0002090_abnormal_vision | 1.14118569 |
| 88 | MP0003075_altered_response_to | 1.12919345 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.10611052 |
| 90 | MP0005023_abnormal_wound_healing | 1.10173475 |
| 91 | MP0003300_gastrointestinal_ulcer | 1.09813766 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 1.09320241 |
| 93 | MP0001984_abnormal_olfaction | 1.07642690 |
| 94 | MP0001873_stomach_inflammation | 1.07419811 |
| 95 | MP0003634_abnormal_glial_cell | 1.05903972 |
| 96 | MP0008874_decreased_physiological_sensi | 1.05903172 |
| 97 | MP0004510_myositis | 1.04614480 |
| 98 | MP0005535_abnormal_body_temperature | 1.04542573 |
| 99 | MP0009697_abnormal_copulation | 1.04278259 |
| 100 | MP0003868_abnormal_feces_composition | 1.03903643 |
| 101 | MP0005058_abnormal_lysosome_morphology | 1.03764926 |
| 102 | MP0001216_abnormal_epidermal_layer | 1.03630962 |
| 103 | MP0003436_decreased_susceptibility_to | 1.02859917 |
| 104 | MP0001661_extended_life_span | 1.00926574 |
| 105 | MP0003045_fibrosis | 1.00726145 |
| 106 | MP0005187_abnormal_penis_morphology | 0.99333169 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.99322102 |
| 108 | MP0008872_abnormal_physiological_respon | 0.98685516 |
| 109 | MP0000371_diluted_coat_color | 0.97915632 |
| 110 | MP0000685_abnormal_immune_system | 0.97466863 |
| 111 | MP0002152_abnormal_brain_morphology | 0.97116669 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.96442811 |
| 113 | MP0002398_abnormal_bone_marrow | 0.96320573 |
| 114 | MP0000627_abnormal_mammary_gland | 0.96262164 |
| 115 | MP0002796_impaired_skin_barrier | 0.95063928 |
| 116 | MP0003632_abnormal_nervous_system | 0.95007065 |
| 117 | MP0003448_altered_tumor_morphology | 0.94237883 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.94186831 |
| 119 | MP0002086_abnormal_extraembryonic_tissu | 0.91858442 |
| 120 | MP0001853_heart_inflammation | 0.91649411 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.91618617 |
| 122 | MP0001177_atelectasis | 0.90957744 |
| 123 | MP0000920_abnormal_myelination | 0.89776350 |
| 124 | MP0005000_abnormal_immune_tolerance | 0.88964459 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.88897484 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.88831489 |
| 127 | MP0004957_abnormal_blastocyst_morpholog | 0.86573199 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.85715850 |
| 129 | MP0001849_ear_inflammation | 0.84940718 |
| 130 | MP0001800_abnormal_humoral_immune | 0.84752472 |
| 131 | MP0001915_intracranial_hemorrhage | 0.84453570 |
| 132 | MP0000733_abnormal_muscle_development | 0.84160970 |
| 133 | MP0001730_embryonic_growth_arrest | 0.83273952 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.83075588 |
| 135 | MP0003122_maternal_imprinting | 0.82613253 |
| 136 | MP0002419_abnormal_innate_immunity | 0.82443387 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.80915602 |
| 138 | * MP0003077_abnormal_cell_cycle | 0.80810079 |
| 139 | MP0002722_abnormal_immune_system | 0.79778989 |
| 140 | MP0005623_abnormal_meninges_morphology | 0.78433112 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.78432384 |
| 142 | MP0002405_respiratory_system_inflammati | 0.78316730 |
| 143 | MP0005501_abnormal_skin_physiology | 0.78209681 |
| 144 | MP0003252_abnormal_bile_duct | 0.77763069 |
| 145 | * MP0005384_cellular_phenotype | 0.77710817 |
| 146 | MP0000609_abnormal_liver_physiology | 0.77318258 |
| 147 | MP0002971_abnormal_brown_adipose | 0.77026689 |
| 148 | MP0003111_abnormal_nucleus_morphology | 0.76244170 |
| 149 | MP0003984_embryonic_growth_retardation | 0.76176728 |
| 150 | MP0005387_immune_system_phenotype | 0.76158140 |
| 151 | MP0001790_abnormal_immune_system | 0.76158140 |
| 152 | MP0008007_abnormal_cellular_replicative | 0.75312038 |
| 153 | MP0009115_abnormal_fat_cell | 0.74618373 |
| 154 | MP0002896_abnormal_bone_mineralization | 0.74522140 |
| 155 | MP0002420_abnormal_adaptive_immunity | 0.74052666 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.73835392 |
| 157 | MP0000689_abnormal_spleen_morphology | 0.73791687 |
| 158 | MP0001819_abnormal_immune_cell | 0.72974683 |
| 159 | MP0002088_abnormal_embryonic_growth/wei | 0.72843410 |
| 160 | MP0002019_abnormal_tumor_incidence | 0.72296802 |
| 161 | MP0001881_abnormal_mammary_gland | 0.71056752 |
| 162 | MP0005166_decreased_susceptibility_to | 0.69327919 |
| 163 | MP0004085_abnormal_heartbeat | 0.66362275 |
| 164 | MP0001905_abnormal_dopamine_level | 0.66274301 |
| 165 | MP0001348_abnormal_lacrimal_gland | 0.64962045 |
| 166 | MP0000747_muscle_weakness | 0.64644599 |
| 167 | MP0004233_abnormal_muscle_weight | 0.63532729 |
| 168 | MP0004142_abnormal_muscle_tone | 0.61974889 |
| 169 | MP0003183_abnormal_peptide_metabolism | 0.58131267 |
| 170 | MP0005253_abnormal_eye_physiology | 0.57476328 |
| 171 | MP0004742_abnormal_vestibular_system | 0.57396910 |
| 172 | MP0004484_altered_response_of | 0.56593349 |
| 173 | MP0002752_abnormal_somatic_nervous | 0.55279957 |
| 174 | MP0003283_abnormal_digestive_organ | 0.53546954 |
| 175 | MP0005076_abnormal_cell_differentiation | 0.52205283 |
| 176 | MP0000003_abnormal_adipose_tissue | 0.51091080 |
| 177 | MP0002877_abnormal_melanocyte_morpholog | 0.48646584 |
| 178 | MP0010769_abnormal_survival | 0.48410058 |
| 179 | MP0002089_abnormal_postnatal_growth/wei | 0.47496121 |
| 180 | MP0004185_abnormal_adipocyte_glucose | 0.47336588 |
| 181 | MP0003705_abnormal_hypodermis_morpholog | 0.47130953 |
| 182 | MP0003956_abnormal_body_size | 0.46471403 |
| 183 | MP0001943_abnormal_respiration | 0.45492210 |
| 184 | MP0000751_myopathy | 0.45435837 |
| 185 | MP0000639_abnormal_adrenal_gland | 0.44860862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.43786201 |
| 2 | Focal motor seizures (HP:0011153) | 5.15394064 |
| 3 | Focal seizures (HP:0007359) | 4.59261273 |
| 4 | Visual hallucinations (HP:0002367) | 4.57821484 |
| 5 | Papilledema (HP:0001085) | 4.43664198 |
| 6 | Action tremor (HP:0002345) | 4.19412756 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.90288468 |
| 8 | Osteolytic defects of the hand bones (HP:0009699) | 3.67748981 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.67748981 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.59276419 |
| 11 | Mutism (HP:0002300) | 3.44264928 |
| 12 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.35759746 |
| 13 | Termporal pattern (HP:0011008) | 3.32012055 |
| 14 | Insidious onset (HP:0003587) | 3.32012055 |
| 15 | Epileptic encephalopathy (HP:0200134) | 3.20989566 |
| 16 | Absence seizures (HP:0002121) | 3.19816903 |
| 17 | Atonic seizures (HP:0010819) | 3.14460502 |
| 18 | Postural instability (HP:0002172) | 3.13658029 |
| 19 | Ankle clonus (HP:0011448) | 3.11009537 |
| 20 | Truncal ataxia (HP:0002078) | 3.10412874 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.10393158 |
| 22 | Abnormality of oral frenula (HP:0000190) | 3.08368091 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.07150196 |
| 24 | Subacute progressive viral hepatitis (HP:0006572) | 3.02955512 |
| 25 | Febrile seizures (HP:0002373) | 3.01226879 |
| 26 | Depression (HP:0000716) | 3.00880783 |
| 27 | Urinary urgency (HP:0000012) | 3.00565042 |
| 28 | Spinal cord lesions (HP:0100561) | 2.95537352 |
| 29 | Syringomyelia (HP:0003396) | 2.95537352 |
| 30 | Impaired social interactions (HP:0000735) | 2.89571561 |
| 31 | Abnormal social behavior (HP:0012433) | 2.89571561 |
| 32 | Poor eye contact (HP:0000817) | 2.86189067 |
| 33 | Genetic anticipation (HP:0003743) | 2.83124831 |
| 34 | Macroorchidism (HP:0000053) | 2.82773279 |
| 35 | Dialeptic seizures (HP:0011146) | 2.78519215 |
| 36 | Dysmetric saccades (HP:0000641) | 2.65211819 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.64846347 |
| 38 | Drooling (HP:0002307) | 2.59548365 |
| 39 | Excessive salivation (HP:0003781) | 2.59548365 |
| 40 | Dysmetria (HP:0001310) | 2.58928917 |
| 41 | Broad-based gait (HP:0002136) | 2.58748573 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.58574277 |
| 43 | Arterial tortuosity (HP:0005116) | 2.57533024 |
| 44 | Intention tremor (HP:0002080) | 2.56677806 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.55735691 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.53667213 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.52985303 |
| 48 | Acute myeloid leukemia (HP:0004808) | 2.52745740 |
| 49 | Papillary thyroid carcinoma (HP:0002895) | 2.52254128 |
| 50 | Sparse lateral eyebrow (HP:0005338) | 2.52239727 |
| 51 | Spastic gait (HP:0002064) | 2.49887333 |
| 52 | Gaze-evoked nystagmus (HP:0000640) | 2.47377461 |
| 53 | Hemiplegia (HP:0002301) | 2.46484137 |
| 54 | Abnormality of the corticospinal tract (HP:0002492) | 2.45033594 |
| 55 | Inappropriate behavior (HP:0000719) | 2.41958105 |
| 56 | Slow saccadic eye movements (HP:0000514) | 2.41006906 |
| 57 | Torticollis (HP:0000473) | 2.39917764 |
| 58 | Fatigue (HP:0012378) | 2.38755926 |
| 59 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.35317226 |
| 60 | Anxiety (HP:0000739) | 2.34769562 |
| 61 | Deep philtrum (HP:0002002) | 2.33860994 |
| 62 | Absent frontal sinuses (HP:0002688) | 2.30923903 |
| 63 | Bradykinesia (HP:0002067) | 2.30823117 |
| 64 | Agitation (HP:0000713) | 2.30534346 |
| 65 | Neurofibrillary tangles (HP:0002185) | 2.29127771 |
| 66 | Pheochromocytoma (HP:0002666) | 2.28690154 |
| 67 | Flat acetabular roof (HP:0003180) | 2.27131237 |
| 68 | Megalencephaly (HP:0001355) | 2.26286197 |
| 69 | Vascular tortuosity (HP:0004948) | 2.25677605 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.25423212 |
| 71 | Diplopia (HP:0000651) | 2.25423212 |
| 72 | T lymphocytopenia (HP:0005403) | 2.24891236 |
| 73 | Asymmetry of the thorax (HP:0001555) | 2.24241200 |
| 74 | Spondylolisthesis (HP:0003302) | 2.22865545 |
| 75 | Insomnia (HP:0100785) | 2.22689924 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.22186346 |
| 77 | Scanning speech (HP:0002168) | 2.21841060 |
| 78 | Stereotypic behavior (HP:0000733) | 2.18680859 |
| 79 | Relative macrocephaly (HP:0004482) | 2.17122932 |
| 80 | Progressive inability to walk (HP:0002505) | 2.17016858 |
| 81 | Central scotoma (HP:0000603) | 2.14998628 |
| 82 | Aqueductal stenosis (HP:0002410) | 2.14451039 |
| 83 | Ventricular fibrillation (HP:0001663) | 2.14124865 |
| 84 | Coarse hair (HP:0002208) | 2.13791450 |
| 85 | Lower limb muscle weakness (HP:0007340) | 2.13144923 |
| 86 | Pointed chin (HP:0000307) | 2.09041205 |
| 87 | Apathy (HP:0000741) | 2.08567622 |
| 88 | Resting tremor (HP:0002322) | 2.08422273 |
| 89 | Curly hair (HP:0002212) | 2.07314982 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 2.07182609 |
| 91 | Increased mean platelet volume (HP:0011877) | 2.07180348 |
| 92 | Impaired vibratory sensation (HP:0002495) | 2.06827454 |
| 93 | Viral hepatitis (HP:0006562) | 2.06444524 |
| 94 | Short nail (HP:0001799) | 2.03444513 |
| 95 | Focal dystonia (HP:0004373) | 2.02659155 |
| 96 | Mitral stenosis (HP:0001718) | 2.02148733 |
| 97 | Vertebral compression fractures (HP:0002953) | 2.00686810 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 1.99585955 |
| 99 | Periodontitis (HP:0000704) | 1.99471226 |
| 100 | Ankyloglossia (HP:0010296) | 1.98858961 |
| 101 | Abnormal platelet volume (HP:0011876) | 1.98287421 |
| 102 | Interstitial pulmonary disease (HP:0006530) | 1.97828892 |
| 103 | Glucose intolerance (HP:0000833) | 1.97696357 |
| 104 | Hypercortisolism (HP:0001578) | 1.95865973 |
| 105 | Hyperventilation (HP:0002883) | 1.94858949 |
| 106 | Postural tremor (HP:0002174) | 1.94816103 |
| 107 | Recurrent viral infections (HP:0004429) | 1.94788091 |
| 108 | Abnormality of T cell number (HP:0011839) | 1.94378924 |
| 109 | Status epilepticus (HP:0002133) | 1.93955011 |
| 110 | Tetraparesis (HP:0002273) | 1.93929025 |
| 111 | Menstrual irregularities (HP:0000858) | 1.93795557 |
| 112 | Rapidly progressive (HP:0003678) | 1.93564204 |
| 113 | Annular pancreas (HP:0001734) | 1.93410044 |
| 114 | Broad face (HP:0000283) | 1.92720084 |
| 115 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92413609 |
| 116 | Heterotopia (HP:0002282) | 1.92327242 |
| 117 | Premature rupture of membranes (HP:0001788) | 1.92098927 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.91796211 |
| 119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.90800088 |
| 120 | Neonatal hypoglycemia (HP:0001998) | 1.90618001 |
| 121 | Dilatation of the ascending aorta (HP:0005111) | 1.90381037 |
| 122 | Cutaneous melanoma (HP:0012056) | 1.89178725 |
| 123 | Amblyopia (HP:0000646) | 1.87962439 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87892307 |
| 125 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87769583 |
| 126 | Myocardial infarction (HP:0001658) | 1.87719933 |
| 127 | Chronic diarrhea (HP:0002028) | 1.86920110 |
| 128 | Craniofacial dystonia (HP:0012179) | 1.86776458 |
| 129 | Clonus (HP:0002169) | 1.86587596 |
| 130 | Hammertoe (HP:0001765) | 1.85041168 |
| 131 | Abnormality of the fingertips (HP:0001211) | 1.84969788 |
| 132 | Limb dystonia (HP:0002451) | 1.84337828 |
| 133 | Micronodular cirrhosis (HP:0001413) | 1.84312643 |
| 134 | Hyperacusis (HP:0010780) | 1.83770500 |
| 135 | Overgrowth (HP:0001548) | 1.83206747 |
| 136 | Colitis (HP:0002583) | 1.83101204 |
| 137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82928120 |
| 138 | Rigidity (HP:0002063) | 1.82800352 |
| 139 | Diminished motivation (HP:0000745) | 1.82582394 |
| 140 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.81958494 |
| 141 | Cubitus valgus (HP:0002967) | 1.81677118 |
| 142 | Tetraplegia (HP:0002445) | 1.80542001 |
| 143 | Neuroendocrine neoplasm (HP:0100634) | 1.79970409 |
| 144 | Subaortic stenosis (HP:0001682) | 1.79961272 |
| 145 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.79961272 |
| 146 | Spastic tetraparesis (HP:0001285) | 1.79117379 |
| 147 | Intellectual disability, profound (HP:0002187) | 1.78559671 |
| 148 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.78510231 |
| 149 | Lower limb asymmetry (HP:0100559) | 1.78233913 |
| 150 | Bundle branch block (HP:0011710) | 1.77902176 |
| 151 | Polycythemia (HP:0001901) | 1.77342105 |
| 152 | Abnormality of saccadic eye movements (HP:0000570) | 1.77167526 |
| 153 | Orthostatic hypotension (HP:0001278) | 1.77084215 |
| 154 | Epileptiform EEG discharges (HP:0011182) | 1.76896463 |
| 155 | EEG with generalized epileptiform discharges (HP:0011198) | 1.76883793 |
| 156 | Abnormal glucose tolerance (HP:0001952) | 1.76385412 |
| 157 | Hypsarrhythmia (HP:0002521) | 1.75047274 |
| 158 | Gait ataxia (HP:0002066) | 1.74739948 |
| 159 | Entropion (HP:0000621) | 1.74370947 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.72947586 |
| 161 | Abnormality of macular pigmentation (HP:0008002) | 1.72743653 |
| 162 | Gingivitis (HP:0000230) | 1.72030742 |
| 163 | Aortic aneurysm (HP:0004942) | 1.71904874 |
| 164 | Autoimmune hemolytic anemia (HP:0001890) | 1.71803079 |
| 165 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.71448970 |
| 166 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.71119823 |
| 167 | Increased connective tissue (HP:0009025) | 1.69945001 |
| 168 | Wormian bones (HP:0002645) | 1.68995829 |
| 169 | Abnormality of the gastric mucosa (HP:0004295) | 1.67486013 |
| 170 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.67239292 |
| 171 | Cellulitis (HP:0100658) | 1.64186955 |
| 172 | Freckling (HP:0001480) | 1.63200203 |
| 173 | Spontaneous hematomas (HP:0007420) | 1.62327896 |
| 174 | Vertebral arch anomaly (HP:0008438) | 1.61115784 |
| 175 | Abnormal foot bone ossification (HP:0010675) | 1.60956432 |
| 176 | Thickened calvaria (HP:0002684) | 1.59459108 |
| 177 | Osteomyelitis (HP:0002754) | 1.59395403 |
| 178 | Thyroid carcinoma (HP:0002890) | 1.58277932 |
| 179 | Lower limb hyperreflexia (HP:0002395) | 1.57542584 |
| 180 | Decreased motor nerve conduction velocity (HP:0003431) | 1.57403243 |
| 181 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.57233881 |
| 182 | Dislocated radial head (HP:0003083) | 1.56261621 |
| 183 | Deviation of the thumb (HP:0009603) | 1.54188244 |
| 184 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.52814879 |
| 185 | Sandal gap (HP:0001852) | 1.52434550 |
| 186 | Gastrointestinal inflammation (HP:0004386) | 1.51711983 |
| 187 | Bladder neoplasm (HP:0009725) | 1.51337104 |
| 188 | Bladder carcinoma (HP:0002862) | 1.51337104 |
| 189 | Germ cell neoplasia (HP:0100728) | 1.51148202 |
| 190 | Protrusio acetabuli (HP:0003179) | 1.50904951 |
| 191 | Short chin (HP:0000331) | 1.50813842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.54944324 |
| 2 | NTRK3 | 3.86098291 |
| 3 | PRPF4B | 3.22121883 |
| 4 | MST1R | 3.19809572 |
| 5 | MAP3K4 | 3.07055242 |
| 6 | MARK1 | 3.01659318 |
| 7 | TRPM7 | 3.01090722 |
| 8 | KSR2 | 2.85074773 |
| 9 | MINK1 | 2.70067854 |
| 10 | PAK6 | 2.47428760 |
| 11 | CDK12 | 2.42257669 |
| 12 | EPHA4 | 2.32776926 |
| 13 | MAP3K14 | 2.22781588 |
| 14 | BMPR2 | 2.19387259 |
| 15 | MAP2K4 | 2.15718014 |
| 16 | NEK9 | 2.13179146 |
| 17 | MAP3K2 | 2.05850670 |
| 18 | CAMKK1 | 2.05383151 |
| 19 | LATS2 | 2.04208746 |
| 20 | EIF2AK1 | 2.00465627 |
| 21 | NTRK1 | 1.99006999 |
| 22 | MAP2K7 | 1.95061337 |
| 23 | DAPK2 | 1.81609191 |
| 24 | PRKD3 | 1.79198620 |
| 25 | RET | 1.74907610 |
| 26 | NTRK2 | 1.74081482 |
| 27 | STK38 | 1.73880266 |
| 28 | CDK6 | 1.67273160 |
| 29 | SCYL2 | 1.65881721 |
| 30 | TTN | 1.65321255 |
| 31 | RIPK4 | 1.62043318 |
| 32 | EEF2K | 1.59733715 |
| 33 | TAOK1 | 1.57033672 |
| 34 | IRAK3 | 1.54373578 |
| 35 | KSR1 | 1.54194734 |
| 36 | MAP3K12 | 1.49944181 |
| 37 | ICK | 1.45309388 |
| 38 | BRD4 | 1.40954664 |
| 39 | EIF2AK3 | 1.39849933 |
| 40 | MAP2K3 | 1.39781161 |
| 41 | CDK5 | 1.38449703 |
| 42 | CAMK1G | 1.36891603 |
| 43 | TYK2 | 1.31264524 |
| 44 | MET | 1.30584839 |
| 45 | ALK | 1.30300924 |
| 46 | PRKCH | 1.27855231 |
| 47 | TYRO3 | 1.26740234 |
| 48 | MAP3K13 | 1.26068666 |
| 49 | SIK2 | 1.24324686 |
| 50 | SIK3 | 1.20046654 |
| 51 | EPHA2 | 1.19277124 |
| 52 | AKT3 | 1.18936398 |
| 53 | FGFR4 | 1.18411308 |
| 54 | LMTK2 | 1.16231458 |
| 55 | SGK3 | 1.14564705 |
| 56 | RIPK1 | 1.11614023 |
| 57 | YES1 | 1.11112234 |
| 58 | MAP3K10 | 1.10852667 |
| 59 | MELK | 1.07911918 |
| 60 | GRK5 | 1.06007803 |
| 61 | TRIB3 | 1.05866251 |
| 62 | ERBB3 | 1.04334080 |
| 63 | JAK3 | 1.02742319 |
| 64 | STK11 | 1.00829268 |
| 65 | FES | 1.00357244 |
| 66 | PDK1 | 0.99533406 |
| 67 | BRSK2 | 0.98305102 |
| 68 | ZAP70 | 0.97971758 |
| 69 | MST4 | 0.96756135 |
| 70 | WNK1 | 0.95599422 |
| 71 | PBK | 0.95512160 |
| 72 | CAMKK2 | 0.93299162 |
| 73 | PAK4 | 0.93243170 |
| 74 | STK10 | 0.93014240 |
| 75 | PHKG1 | 0.92667182 |
| 76 | PHKG2 | 0.92667182 |
| 77 | CAMK1D | 0.92623171 |
| 78 | STK3 | 0.92317061 |
| 79 | PAK3 | 0.91908424 |
| 80 | CSNK1G2 | 0.90991596 |
| 81 | SGK2 | 0.89314776 |
| 82 | SGK494 | 0.89171471 |
| 83 | SGK223 | 0.89171471 |
| 84 | MAP3K3 | 0.89046481 |
| 85 | SMG1 | 0.88189400 |
| 86 | SIK1 | 0.87878281 |
| 87 | PDPK1 | 0.85769350 |
| 88 | PLK2 | 0.85417843 |
| 89 | DAPK1 | 0.85328060 |
| 90 | RAF1 | 0.84192517 |
| 91 | FGFR2 | 0.81709381 |
| 92 | PRKCG | 0.81651299 |
| 93 | ARAF | 0.81478615 |
| 94 | MAP3K1 | 0.81122010 |
| 95 | EPHB1 | 0.80923743 |
| 96 | FRK | 0.77981652 |
| 97 | ERBB4 | 0.76754932 |
| 98 | RPS6KB2 | 0.76333126 |
| 99 | PTK2 | 0.75862298 |
| 100 | NEK6 | 0.75282107 |
| 101 | PKN2 | 0.75206614 |
| 102 | NEK1 | 0.74084906 |
| 103 | TGFBR2 | 0.73727218 |
| 104 | MAPK11 | 0.72277831 |
| 105 | PNCK | 0.70562071 |
| 106 | ERN1 | 0.69869759 |
| 107 | CDK14 | 0.68432928 |
| 108 | SGK1 | 0.67748979 |
| 109 | CSK | 0.67714938 |
| 110 | MTOR | 0.67370918 |
| 111 | FGFR3 | 0.66495402 |
| 112 | MARK2 | 0.66430346 |
| 113 | DMPK | 0.65768231 |
| 114 | CDK15 | 0.65678448 |
| 115 | BLK | 0.65437952 |
| 116 | CDK18 | 0.64932179 |
| 117 | CAMK1 | 0.64472603 |
| 118 | MAP3K7 | 0.63022323 |
| 119 | PDGFRA | 0.62841267 |
| 120 | JAK1 | 0.62239818 |
| 121 | MAPK13 | 0.62061922 |
| 122 | STK39 | 0.60887012 |
| 123 | UHMK1 | 0.60259771 |
| 124 | TSSK6 | 0.60252013 |
| 125 | MAP3K8 | 0.59488242 |
| 126 | PDGFRB | 0.58730958 |
| 127 | MAPK10 | 0.56788274 |
| 128 | TEC | 0.56399447 |
| 129 | PRKCZ | 0.56357850 |
| 130 | CAMK2A | 0.55919838 |
| 131 | LATS1 | 0.55363152 |
| 132 | PAK2 | 0.54867641 |
| 133 | FYN | 0.54771244 |
| 134 | CDK19 | 0.54538357 |
| 135 | PIK3CG | 0.54483681 |
| 136 | CDK11A | 0.53128208 |
| 137 | RPS6KA3 | 0.52035814 |
| 138 | JAK2 | 0.48682380 |
| 139 | BTK | 0.48677758 |
| 140 | HCK | 0.48434209 |
| 141 | RPS6KA2 | 0.47863559 |
| 142 | RPS6KB1 | 0.47503569 |
| 143 | CDK4 | 0.47261694 |
| 144 | EIF2AK2 | 0.46687200 |
| 145 | BMX | 0.46306881 |
| 146 | PTK6 | 0.46035263 |
| 147 | MAP2K1 | 0.45479525 |
| 148 | STK24 | 0.44147861 |
| 149 | IRAK4 | 0.44113500 |
| 150 | MOS | 0.42041155 |
| 151 | MAP3K5 | 0.40102989 |
| 152 | MAP3K6 | 0.40100464 |
| 153 | IRAK1 | 0.39713700 |
| 154 | TNK2 | 0.39382410 |
| 155 | LRRK2 | 0.38389882 |
| 156 | FER | 0.36936589 |
| 157 | ILK | 0.36662029 |
| 158 | TTK | 0.36066881 |
| 159 | STK4 | 0.35930130 |
| 160 | OXSR1 | 0.34790062 |
| 161 | CDC42BPA | 0.34095372 |
| 162 | DYRK1A | 0.33692145 |
| 163 | PRKCB | 0.33500021 |
| 164 | PRKAA1 | 0.33032496 |
| 165 | PTK2B | 0.31061482 |
| 166 | PINK1 | 0.28588663 |
| 167 | CSNK1D | 0.28275665 |
| 168 | HIPK2 | 0.27986086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.76087166 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36149985 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32038844 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.31926507 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.29571728 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19860400 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09230790 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.03063776 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.92109512 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85433156 |
| 11 | Thyroid cancer_Homo sapiens_hsa05216 | 1.85317640 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.85293291 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.83812880 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79924733 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78373475 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.77320321 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.70738231 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.70120870 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69197433 |
| 20 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.68320773 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67922721 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64427862 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.59884944 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.55684400 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54529574 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51100062 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.48732926 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44948212 |
| 29 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42960292 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.42953079 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42745359 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.41975971 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.39690638 |
| 34 | Prostate cancer_Homo sapiens_hsa05215 | 1.36352911 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.36014501 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35637886 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33953247 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30418125 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.29384841 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23371502 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.23146896 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.22671048 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.21706820 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21547592 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20991997 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.20757659 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.19158311 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 1.17852653 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.14048811 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 1.13943247 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13856568 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13427713 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11817308 |
| 54 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.11105342 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10744356 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10586187 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 1.10581639 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09810947 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08385959 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07989411 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07778872 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07775883 |
| 63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06952083 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 1.02651511 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01460045 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00775663 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00656846 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98567044 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97862079 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.97373582 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93739155 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.93598976 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.92954807 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92567390 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91338110 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89680913 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89485161 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87784981 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87490075 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86328177 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.85673797 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83903458 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83703943 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.83189215 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.82135511 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.81972085 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.80859660 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80769452 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80191419 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.79712852 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79240394 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76466065 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76413993 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75602965 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.73855003 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73333516 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72708211 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72068350 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70290682 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.70160433 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70145962 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70002645 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69159640 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67674081 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66745300 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65347232 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65074495 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64716451 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64278780 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63899672 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62976277 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62904882 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62650238 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61875584 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61342435 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60988438 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60752013 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60354021 |
| 119 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59938812 |
| 120 | Malaria_Homo sapiens_hsa05144 | 0.59872833 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.59552317 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58943183 |
| 123 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58245437 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57878067 |
| 125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57740810 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57585790 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57468967 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57323507 |
| 129 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56930307 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.56076738 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56016735 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54801598 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54546422 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53748090 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53643068 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53379745 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53332742 |
| 138 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53286400 |
| 139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52671089 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.51784678 |
| 141 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51154566 |
| 142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49647307 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47937961 |
| 144 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47423001 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47155840 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.46548893 |
| 147 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46450818 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46256801 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45913810 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.45673735 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44520020 |
| 152 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43507740 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38253309 |
| 154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37733514 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37689633 |

